Search

for
Search:

GlossaryDupilumab

monoclonal antibody treating inflammatory conditions like eczema and asthma

Dupilumab is a monoclonal antibody medication used to treat certain inflammatory conditions like eczema (atopic dermatitis) and asthma. It works by blocking specific proteins (IL-4 and IL-13) involved in the body's immune response, thereby reducing inflammation and symptoms.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 241 results

research Dupilumab in Inflammatory Skin Diseases: A Systematic Review

72 citations , March 2023 in “Biomolecules”

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

research Alopecia Areata After Dupilumab for Atopic Dermatitis

53 citations , January 2018 in “JAAD case reports”

Dupilumab for eczema may cause hair loss.

research Dupilumab: A Review of Present Indications and Off-Label Uses

50 citations , March 2021 in “Journal of investigational allergology & clinical immunology”

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

research Drug-Induced Alopecia After Dupilumab Therapy

49 citations , December 2018 in “JAAD case reports”

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

research Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report

33 citations , January 2019 in “Acta Dermato Venereologica”

Dupilumab may help regrow hair in people with atopic dermatitis.

View more "dupilumab" in research →

Community Join

1 / 1 results

community 2020 Hair and Scalp Treatments: A Clinical Guide (in Depth 350 Page Guide)

in Treatment 65 upvotes 5 years ago

Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.